AI Scribe for Hematologists
Document blood disorders, anticoagulation, and thrombosis in seconds. PatientNotes tracks INR trends, analyzes CBCs, and generates comprehensive hematology assessments.

Documentation for Every Hematology Visit
From anemia workup to anticoagulation management, PatientNotes handles all hematology documentation needs
Anemia Workup
Comprehensive anemia evaluation with CBC interpretation, iron studies, and differential diagnosis.
Anticoagulation Management
Warfarin dosing, DOAC therapy, INR monitoring, and bleeding risk assessment for DVT/PE and AFib.
Thrombosis Evaluation
DVT/PE diagnosis and management, thrombophilia testing, and long-term anticoagulation planning.
Coagulation Disorders
Hemophilia, von Willebrand disease, platelet disorders, and factor deficiency management.
Hematologic Malignancy
Leukemia, lymphoma, myeloma management with chemotherapy documentation and response tracking.
Bone Marrow Disorders
Myelodysplastic syndromes, aplastic anemia, and bone marrow failure syndrome documentation.
Hematology-Specific Features
Built for the unique documentation needs of hematology
Anticoagulation Dosing
Track warfarin dose adjustments with INR trends, calculate therapeutic ranges, and document DOAC therapy with renal dosing considerations.
CBC Interpretation
Automatic analysis of complete blood count with MCV classification, RDW, reticulocyte index, and differential diagnosis generation.
Bleeding Risk Scores
Calculate HAS-BLED scores for anticoagulation bleeding risk and document risk mitigation strategies.
Thrombophilia Panel
Systematically document Factor V Leiden, prothrombin mutation, protein C/S, antithrombin, antiphospholipid antibodies, and genetic testing.
Chemotherapy Tracking
Document chemotherapy protocols, cycle numbers, dose reductions, growth factor support, and treatment response for hematologic cancers.
Transfusion Documentation
Track red cell, platelet, and plasma transfusions with pre/post counts, reactions, and transfusion thresholds.
Sample AI-Generated Hematology Note
See how PatientNotes documents a DVT evaluation with thrombophilia workup
SUBJECTIVE: 56-year-old female referred for evaluation of unprovoked left lower extremity DVT diagnosed 2 weeks ago. Patient presented to ED with left leg swelling and pain. Doppler ultrasound showed acute DVT involving left popliteal and femoral veins. Started on rivaroxaban 15mg BID. No prior history of VTE. No recent surgery, travel, or immobilization. Family history significant for mother with PE at age 62. No active bleeding. Denies shortness of breath or chest pain. OBJECTIVE: Vitals: BP 128/76, HR 78, RR 16, SpO2 98% RA General: Well-appearing, no acute distress Cardiovascular: Regular rate and rhythm, no murmurs Lungs: Clear to auscultation bilaterally Left Lower Extremity: Mild residual edema (2cm difference in calf circumference compared to right), no erythema, homans sign negative, pulses intact LABS (from 2 weeks ago at DVT diagnosis): - CBC: WBC 7.2, Hgb 13.8, Plt 245,000 - PT/INR: 1.0 - aPTT: 28 seconds - D-dimer: 3,245 ng/mL (elevated) - CrCl: 82 mL/min LABS (today - thrombophilia workup): - Factor V Leiden: Positive (heterozygous) - Prothrombin G20210A mutation: Negative - Protein C activity: 98% (normal) - Protein S activity: 102% (normal) - Antithrombin III: 96% (normal) - Lupus anticoagulant: Negative - Anticardiolipin antibody: Negative - Anti-beta-2-glycoprotein I: Negative - Homocysteine: 8.2 mcmol/L (normal) IMAGING: - Lower extremity doppler (today): Partial recanalization of left femoral vein, residual thrombus in popliteal vein, no extension ASSESSMENT: 1. Unprovoked left lower extremity deep vein thrombosis - Currently on rivaroxaban 15mg BID (acute phase dosing) - Clinical improvement with partial recanalization 2. Factor V Leiden heterozygous - likely contributing thrombophilia 3. Family history of venous thromboembolism (mother with PE) PLAN: 1. Continue rivaroxaban 15mg BID for total 21 days (10 more days remaining), then transition to 20mg once daily 2. Extended anticoagulation recommended given: - Unprovoked DVT - Factor V Leiden heterozygous - Positive family history - Low bleeding risk (HAS-BLED score: 0) 3. Plan for indefinite anticoagulation unless contraindication develops 4. Discussed risks/benefits of long-term anticoagulation 5. Bleeding precautions reviewed 6. Compression stockings 20-30 mmHg for post-thrombotic syndrome prevention 7. Repeat doppler ultrasound in 3 months to assess for recanalization 8. Avoid estrogen-containing medications 9. Genetic counseling offered for family members 10. Follow-up in 3 months with repeat CBC, CrCl 11. Advised to contact immediately if: severe bleeding, severe headache, chest pain, severe leg swelling 12. Provided anticoagulation wallet card and emergency contact information
Intelligent ICD-10 Suggestions
PatientNotes suggests the codes most commonly used in hematology
D64.9Anemia, unspecifiedD50.9Iron deficiency anemia, unspecifiedI82.40Acute embolism and thrombosis of unspecified deep veins of lower extremityD68.9Coagulation defect, unspecifiedD69.6Thrombocytopenia, unspecifiedD68.61Antiphospholipid syndromeZ79.01Long term (current) use of anticoagulantsD66Hereditary factor VIII deficiency (Hemophilia A)AI suggests relevant codes based on your documentation—review and select with one click.
Frequently Asked Questions
Can PatientNotes track anticoagulation therapy?
Yes. PatientNotes documents warfarin dosing with INR trends, DOAC therapy (apixaban, rivaroxaban, dabigatran), indication for anticoagulation, bleeding risk assessment (HAS-BLED), and monitoring intervals. It tracks dose adjustments and therapeutic ranges.
Does PatientNotes support anemia workup documentation?
Yes. PatientNotes captures CBC analysis, MCV classification (microcytic, normocytic, macrocytic), iron studies, B12/folate levels, reticulocyte count, and differential diagnosis. It generates comprehensive anemia assessment and treatment plans.
How does PatientNotes handle thrombosis evaluation?
PatientNotes documents DVT/PE workup, thrombophilia testing (Factor V Leiden, prothrombin mutation, protein C/S, antithrombin), treatment duration, and recurrence risk. It tracks D-dimer trends and imaging results.
Can PatientNotes document hematologic malignancies?
Yes. PatientNotes supports documentation for leukemia, lymphoma, and myeloma including staging, treatment protocols, chemotherapy cycles, response assessment, and surveillance. It tracks blood counts, flow cytometry, and bone marrow results.
See More Patients, Document Less
Join hematologists saving 2+ hours daily on documentation. PatientNotes handles the charting so you can focus on your patients.
No credit card required. $50/month after trial.